Biomarker Testing in RCC: Current Approaches

Video

David Aggen, MD, PhD reviews how he currently approaches biomarker testing in patients with RCC.

Recent Videos
Given resource scarcity, developing practice strategies for resource-constrained settings would require aid from commercial and government stakeholders.
Large international meetings may facilitate conversations regarding disparities of care outside of high-income countries.
Observing changes in the tumor microenvironment before and after a biopsy may elucidate how kidney cancer cells interact with immune cells.
Related Content